George D. Yancopoulos

164.0k total citations · 70 hit papers
430 papers, 103.1k citations indexed

About

George D. Yancopoulos is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Immunology. According to data from OpenAlex, George D. Yancopoulos has authored 430 papers receiving a total of 103.1k indexed citations (citations by other indexed papers that have themselves been cited), including 246 papers in Molecular Biology, 82 papers in Cellular and Molecular Neuroscience and 74 papers in Immunology. Recurrent topics in George D. Yancopoulos's work include Angiogenesis and VEGF in Cancer (100 papers), Nerve injury and regeneration (39 papers) and Lipid metabolism and disorders (39 papers). George D. Yancopoulos is often cited by papers focused on Angiogenesis and VEGF in Cancer (100 papers), Nerve injury and regeneration (39 papers) and Lipid metabolism and disorders (39 papers). George D. Yancopoulos collaborates with scholars based in United States, Germany and United Kingdom. George D. Yancopoulos's co-authors include Stanley J. Wiegand, Nicholas W. Gale, Samuel Davis, Neil Stahl, David M. Valenzuela, Peter C. Maisonpierre, David J. Glass, Jocelyn Holash, Andrew Murphy and Frederick W. Alt and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

George D. Yancopoulos

428 papers receiving 100.9k citations

Hit Papers

Vascular-specific growth ... 1984 2026 1998 2012 2000 1997 2001 1996 2001 1000 2.0k 3.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Vascular-specific growth factors and blood vessel formation
    2000 3.0k citations George D. Yancopoulos, Nicholas W. Gale et al. Nature profile →
  2. Angiopoietin-2, a Natural Antagonist for Tie2 That Disrupts in vivo Angiogenesis
    1997 2.8k citations Stanley J. Wiegand, Nikolaos G. Papadopoulos et al. Science profile →
  3. Identification of Ubiquitin Ligases Required for Skeletal Muscle Atrophy
    2001 2.8k citations Sue C. Bodine, Esther Latres et al. Science profile →
  4. Requisite Role of Angiopoietin-1, a Ligand for the TIE2 Receptor, during Embryonic Angiogenesis
    1996 2.3k citations George D. Yancopoulos et al. profile →
  5. Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo
    2001 2.1k citations Sue C. Bodine, Trevor N. Stitt et al. profile →
  6. Intravitreal Aflibercept (VEGF Trap-Eye) in Wet Age-related Macular Degeneration
    2012 1.8k citations George D. Yancopoulos, Neil Stahl et al. profile →
  7. Vessel Cooption, Regression, and Growth in Tumors Mediated by Angiopoietins and VEGF
    1999 1.7k citations Jocelyn Holash, George D. Yancopoulos et al. Science profile →
  8. ERKs: A family of protein-serine/threonine kinases that are activated and tyrosine phosphorylated in response to insulin and NGF
    1991 1.7k citations George D. Yancopoulos et al. profile →
  9. Isolation of Angiopoietin-1, a Ligand for the TIE2 Receptor, by Secretion-Trap Expression Cloning
    1996 1.6k citations George D. Yancopoulos et al. profile →
  10. The IGF-1/PI3K/Akt Pathway Prevents Expression of Muscle Atrophy-Induced Ubiquitin Ligases by Inhibiting FOXO Transcription Factors
    2004 1.6k citations Trevor N. Stitt, Brian Clarke et al. profile →
  11. VEGF-Trap: A VEGF blocker with potent antitumor effects
    2002 1.3k citations Jocelyn Holash, Nikolaos G. Papadopoulos et al. Proceedings of the National Academy of Sciences profile →
  12. BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra
    1991 1.3k citations George D. Yancopoulos et al. Nature profile →
  13. Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways
    2001 1.3k citations Sue C. Bodine, Brian Clarke et al. profile →
  14. Regulation of the Germinal Center Response by MicroRNA-155
    2007 1.2k citations Andrew Murphy, David M. Valenzuela et al. Science profile →
  15. Leakage-Resistant Blood Vessels in Mice Transgenically Overexpressing Angiopoietin-1
    1999 1.1k citations Gavin Thurston, George D. Yancopoulos et al. Science profile →
  16. NT-3, BDNF, and NGF in the developing rat nervous system: Parallel as well as reciprocal patterns of expression
    1990 1.1k citations Stanley J. Wiegand, George D. Yancopoulos et al. profile →
  17. Neurotrophin-3: a Neurotrophic Factor Related to NGF and BDNF
    1990 1.1k citations George D. Yancopoulos et al. Science profile →
  18. Angiopoietin-1 protects the adult vasculature against plasma leakage
    2000 1.1k citations Gavin Thurston, John S. Rudge et al. profile →
  19. Mammalian Sir2 Homolog SIRT3 Regulates Global Mitochondrial Lysine Acetylation
    2007 1.0k citations Frederick W. Alt, George D. Yancopoulos et al. profile →
  20. Dupilumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis
    2014 1.0k citations Neil Stahl, George D. Yancopoulos et al. New England Journal of Medicine profile →
  21. Dupilumab in Persistent Asthma with Elevated Eosinophil Levels
    2013 951 citations Neil Stahl, George D. Yancopoulos et al. New England Journal of Medicine profile →
  22. SIRT4 Inhibits Glutamate Dehydrogenase and Opposes the Effects of Calorie Restriction in Pancreatic β Cells
    2006 930 citations Andrew Murphy, David M. Valenzuela et al. profile →
  23. Regulation of Gliogenesis in the Central Nervous System by the JAK-STAT Signaling Pathway
    1997 852 citations Neil Stahl, George D. Yancopoulos et al. Science profile →
  24. Choice of STATs and Other Substrates Specified by Modular Tyrosine-Based Motifs in Cytokine Receptors
    1995 840 citations Neil Stahl, George D. Yancopoulos et al. Science profile →
  25. Association and Activation of Jak-Tyk Kinases by CNTF-LIF-OSM-IL-6 β Receptor Components
    1994 836 citations Neil Stahl, George D. Yancopoulos et al. Science profile →
  26. Blockade of Dll4 inhibits tumour growth by promoting non-productive angiogenesis
    2006 824 citations Irene Noguera‐Troise, Christopher Daly et al. Nature profile →
  27. Binding and neutralization of vascular endothelial growth factor (VEGF) and related ligands by VEGF Trap, ranibizumab and bevacizumab
    2012 823 citations Nicholas Papadopoulos, George D. Yancopoulos et al. profile →
  28. Angiopoietin-2 Is Required for Postnatal Angiogenesis and Lymphatic Patterning, and Only the Latter Role Is Rescued by Angiopoietin-1
    2002 785 citations Nicholas W. Gale, Gavin Thurston et al. profile →
  29. The Receptor Tyrosine Kinase MuSK Is Required for Neuromuscular Junction Formation In Vivo
    1996 749 citations Thomas M. DeChiara, David M. Valenzuela et al. profile →
  30. Eph Receptors and Ligands Comprise Two Major Specificity Subclasses and Are Reciprocally Compartmentalized during Embryogenesis
    1996 731 citations Nicholas W. Gale, David M. Valenzuela et al. profile →
  31. CD133 expression is not restricted to stem cells, and both CD133+ and CD133– metastatic colon cancer cells initiate tumors
    2008 731 citations Andrew Murphy, David M. Valenzuela et al. profile →
  32. trkB encodes a functional receptor for brain-derived neurotrophic factor and neurotrophin-3 but not nerve growth factor
    1991 722 citations Trevor N. Stitt, David J. Glass et al. profile →
  33. Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies
    2020 719 citations Kristen E. Pascal, Min Ni et al. Science profile →
  34. Essential role for oncogenic Ras in tumour maintenance
    1999 697 citations Jocelyn Holash, George D. Yancopoulos et al. Nature profile →
  35. Increased Vascularization in Mice Overexpressing Angiopoietin-1
    1998 680 citations Gavin Thurston, George D. Yancopoulos et al. Science profile →
  36. Innate and Adaptive Interleukin-22 Protects Mice from Inflammatory Bowel Disease
    2008 674 citations George D. Yancopoulos, David M. Valenzuela et al. profile →
  37. Differentiation Stage-Specific Inhibition of the Raf-MEK-ERK Pathway by Akt
    1999 670 citations Brian Clarke, Lorna Nuñez et al. Science profile →
  38. Growth factors acting via endothelial cell-specific receptor tyrosine kinases: VEGFs, Angiopoietins, and ephrins in vascular development
    1999 641 citations Nicholas W. Gale, George D. Yancopoulos profile →
  39. A BDNF autocrine loop in adult sensory neurons prevents cell death
    1995 633 citations Thomas M. DeChiara, George D. Yancopoulos et al. Nature profile →
  40. Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting β2 agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trial
    2016 632 citations Neil Stahl, George D. Yancopoulos et al. profile →
  41. New model of tumor angiogenesis: dynamic balance between vessel regression and growth mediated by angiopoietins and VEGF
    1999 620 citations Jocelyn Holash, Stanley J. Wiegand et al. profile →
  42. Ordered rearrangement of immunoglobulin heavy chain variable region segments.
    1984 610 citations Frederick W. Alt, George D. Yancopoulos et al. profile →
  43. Ligands for EPH-Related Receptor Tyrosine Kinases that Require Membrane Attachment or Clustering for Activity
    1994 610 citations Nicholas W. Gale, George D. Yancopoulos et al. Science profile →
  44. Developmentally controlled and tissue-specific expression of unrearranged VH gene segments
    1985 604 citations George D. Yancopoulos profile →
  45. Multiple growth factors, cytokines, and neurotrophins rescue photoreceptors from the damaging effects of constant light.
    1992 600 citations George D. Yancopoulos et al. Proceedings of the National Academy of Sciences profile →
  46. An Insulin-Stimulated Protein Kinase Similar to Yeast Kinases Involved in Cell Cycle Control
    1990 600 citations George D. Yancopoulos et al. Science profile →
  47. Delta-like ligand 4 (Dll4) is induced by VEGF as a negative regulator of angiogenic sprouting
    2007 597 citations Ivan B. Lobov, R.A. Renard et al. Proceedings of the National Academy of Sciences profile →
  48. CNTF and LIF act on neuronal cells via shared signaling pathways that involve the IL-6 signal transducing receptor component gp130
    1992 593 citations Neil Stahl, George D. Yancopoulos et al. profile →
  49. Inhibition of Vascular Endothelial Growth Factor (VEGF) Signaling in Cancer Causes Loss of Endothelial Fenestrations, Regression of Tumor Vessels, and Appearance of Basement Membrane Ghosts
    2004 589 citations Gavin Thurston, George D. Yancopoulos et al. profile →
  50. IL-22BP is regulated by the inflammasome and modulates tumorigenesis in the intestine
    2012 583 citations Andrew Murphy, David M. Valenzuela et al. Nature profile →
  51. Tie2 Receptor Ligands, Angiopoietin-1 and Angiopoietin-2, Modulate VEGF-Induced Postnatal Neovascularization
    1998 559 citations George D. Yancopoulos et al. profile →
  52. Agrin Acts via a MuSK Receptor Complex
    1996 557 citations David J. Glass, Trevor N. Stitt et al. profile →
  53. LIFRβ and gp130 as Heterodimerizing Signal Transducers of the Tripartite CNTF Receptor
    1993 556 citations Neil Stahl, George D. Yancopoulos et al. Science profile →
  54. Effect of Subcutaneous Dupilumab on Nasal Polyp Burden in Patients With Chronic Sinusitis and Nasal Polyposis
    2016 553 citations Neil Stahl, George D. Yancopoulos et al. profile →
  55. Preferential utilization of the most JH-proximal VH gene segments in pre-B-cell lines
    1984 549 citations George D. Yancopoulos, Frederick W. Alt et al. Nature profile →
  56. Targeting key proximal drivers of type 2 inflammation in disease
    2015 529 citations Neil Stahl, George D. Yancopoulos et al. profile →
  57. Interleukin-22 but Not Interleukin-17 Provides Protection to Hepatocytes during Acute Liver Inflammation
    2007 522 citations George D. Yancopoulos, David M. Valenzuela et al. profile →
  58. Development of the Primary Antibody Repertoire
    1987 518 citations Frederick W. Alt, George D. Yancopoulos et al. Science profile →
  59. The Receptor for Ciliary Neurotrophic Factor
    1991 516 citations David M. Valenzuela, George D. Yancopoulos et al. Science profile →
  60. Effect of a Monoclonal Antibody to PCSK9 on LDL Cholesterol
    2012 505 citations Evan A. Stein, Scott Mellis et al. New England Journal of Medicine profile →
  61. Differential expression of myc family genes during murine development
    1986 480 citations George D. Yancopoulos, Frederick W. Alt et al. Nature profile →
  62. Dupilumab progressively improves systemic and cutaneous abnormalities in patients with atopic dermatitis
    2018 477 citations George D. Yancopoulos et al. profile →
  63. Evinacumab for Homozygous Familial Hypercholesterolemia
    2020 470 citations Frederick J. Raal, Robert S. Rosenson et al. New England Journal of Medicine profile →
  64. RNA Sequencing of Single Human Islet Cells Reveals Type 2 Diabetes Genes
    2016 439 citations Yurong Xin, Min Ni et al. profile →
  65. Dupilumab improves the molecular signature in skin of patients with moderate-to-severe atopic dermatitis
    2014 359 citations George D. Yancopoulos et al. profile →
  66. Dual blockade of IL‐4 and IL‐13 with dupilumab, an IL‐4Rα antibody, is required to broadly inhibit type 2 inflammation
    2019 330 citations Tammy Huang, Nicholas Papadopoulos et al. profile →
  67. Efficacy and Safety of Itepekimab in Patients with Moderate-to-Severe Asthma
    2021 258 citations David M. Weinreich, George D. Yancopoulos et al. New England Journal of Medicine profile →
  68. Dupilumab in patients with prurigo nodularis: two randomized, double-blind, placebo-controlled phase 3 trials
    2023 119 citations George D. Yancopoulos, David M. Weinreich et al. profile →
  69. Dupilumab for COPD with Blood Eosinophil Evidence of Type 2 Inflammation
    2024 102 citations George D. Yancopoulos et al. New England Journal of Medicine profile →
  70. Dupilumab in patients with chronic spontaneous urticaria (LIBERTY-CSU CUPID): Two randomized, double-blind, placebo-controlled, phase 3 trials
    2024 65 citations George D. Yancopoulos et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
George D. Yancopoulos United States 161 55.1k 18.5k 16.0k 14.3k 12.2k 430 103.1k
Peter Carmeliet Belgium 151 53.1k 1.0× 7.0k 0.4× 11.7k 0.7× 15.0k 1.1× 6.4k 0.5× 729 100.0k
Kari Alitalo Finland 161 56.8k 1.0× 8.4k 0.5× 8.3k 0.5× 45.5k 3.2× 10.9k 0.9× 716 94.3k
Pierre Chambon France 183 80.6k 1.5× 9.0k 0.5× 15.8k 1.0× 13.3k 0.9× 5.2k 0.4× 702 117.0k
John C. Reed United States 161 73.3k 1.3× 6.2k 0.3× 20.4k 1.3× 21.4k 1.5× 4.6k 0.4× 799 107.5k
Napoleone Ferrara United States 140 61.5k 1.1× 5.5k 0.3× 10.1k 0.6× 20.6k 1.4× 3.8k 0.3× 259 99.3k
Nahum Sonenberg Canada 160 77.5k 1.4× 5.5k 0.3× 9.1k 0.6× 7.1k 0.5× 4.9k 0.4× 673 97.8k
Neal G. Copeland United States 135 42.7k 0.8× 8.7k 0.5× 13.6k 0.9× 8.0k 0.6× 7.3k 0.6× 622 73.1k
Eric N. Olson United States 199 109.1k 2.0× 9.3k 0.5× 6.8k 0.4× 9.2k 0.6× 10.2k 0.8× 761 135.3k
Steven P. Gygi United States 166 88.4k 1.6× 4.5k 0.2× 7.9k 0.5× 12.4k 0.9× 15.6k 1.3× 695 121.5k
Josef Penninger Austria 133 40.9k 0.7× 4.2k 0.2× 18.0k 1.1× 14.8k 1.0× 4.0k 0.3× 582 78.3k

Countries citing papers authored by George D. Yancopoulos

Since Specialization
Citations

This map shows the geographic impact of George D. Yancopoulos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by George D. Yancopoulos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites George D. Yancopoulos more than expected).

Fields of papers citing papers by George D. Yancopoulos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by George D. Yancopoulos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by George D. Yancopoulos. The network helps show where George D. Yancopoulos may publish in the future.

Co-authorship network of co-authors of George D. Yancopoulos

This figure shows the co-authorship network connecting the top 25 collaborators of George D. Yancopoulos. A scholar is included among the top collaborators of George D. Yancopoulos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with George D. Yancopoulos. George D. Yancopoulos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Adam, Rene C., Yuanqi Zhao, Soo Min, et al.. (2023). Activin E–ACVR1C cross talk controls energy storage via suppression of adipose lipolysis in mice. Proceedings of the National Academy of Sciences. 120(32). e2309967120–e2309967120. 21 indexed citations
2.
Stec, Michael J., Qi Su, Christina Adler, et al.. (2023). A cellular and molecular spatial atlas of dystrophic muscle. Proceedings of the National Academy of Sciences. 120(29). e2221249120–e2221249120. 19 indexed citations
3.
Stein, David, Ernesto Oviedo‐Orta, Wendy Kampman, et al.. (2021). Compassionate Use of REGEN-COV® in Patients With Coronavirus Disease 2019 (COVID-19) and Immunodeficiency-Associated Antibody Disorders. Clinical Infectious Diseases. 75(1). e509–e515. 7 indexed citations
4.
Raal, Frederick J., Robert S. Rosenson, Laurens F. Reeskamp, et al.. (2020). Evinacumab for Homozygous Familial Hypercholesterolemia. New England Journal of Medicine. 383(8). 711–720. 470 indexed citations breakdown →
5.
Cooper, Dennis, Deepu Madduri, Suzanne Lentzsch, et al.. (2019). Safety and Preliminary Clinical Activity of REGN5458, an Anti-Bcma x Anti-CD3 Bispecific Antibody, in Patients with Relapsed/Refractory Multiple Myeloma. Blood. 134(Supplement_1). 3176–3176. 31 indexed citations
6.
Kleiner, Sandra, Daniel R. Gomez, Erqian Na, et al.. (2018). Mice harboring the human SLC30A8 R138X loss-of-function mutation have increased insulin secretory capacity. Proceedings of the National Academy of Sciences. 115(32). E7642–E7649. 40 indexed citations
7.
Eichten, Alexandra, Alexander P. Adler, Li Zhang, et al.. (2016). Resistance to Anti-VEGF Therapy Mediated by Autocrine IL6/STAT3 Signaling and Overcome by IL6 Blockade. Cancer Research. 76(8). 2327–2339. 47 indexed citations
8.
Pascal, Kristen E., Christopher M. Coleman, Alejandro O. Mujica, et al.. (2015). Pre- and postexposure efficacy of fully human antibodies against Spike protein in a novel humanized mouse model of MERS-CoV infection. Proceedings of the National Academy of Sciences. 112(28). 8738–8743. 172 indexed citations
9.
Cheung, Eunice, Ivan B. Lobov, George D. Yancopoulos, & Stanley J. Wiegand. (2014). Inhibiting Platelet Derived Growth Factor Receptor β (PDGFRβ) reduces pericytes coverage and effects vessel morphology and growth in developing retinal vessels in pups but not mature vessels in adult mice. Investigative Ophthalmology & Visual Science. 55(13). 4361–4361. 2 indexed citations
10.
Daly, Christopher, Alexandra Eichten, Carla Castanaro, et al.. (2012). Angiopoietin-2 Functions as a Tie2 Agonist in Tumor Models, Where It Limits the Effects of VEGF Inhibition. Cancer Research. 73(1). 108–118. 180 indexed citations
11.
Stein, Evan A., Scott Mellis, George D. Yancopoulos, et al.. (2012). Effect of a Monoclonal Antibody to PCSK9 on LDL Cholesterol. Obstetrical & Gynecological Survey. 67(7). 413–414. 10 indexed citations
12.
Zhao, Tong‐Jin, Guosheng Liang, Xuefen Xie, et al.. (2010). Ghrelin O -acyltransferase (GOAT) is essential for growth hormone-mediated survival of calorie-restricted mice. Proceedings of the National Academy of Sciences. 107(16). 7467–7472. 358 indexed citations
13.
Giallourakis, Cosmas, Andrew Franklin, Chunguang Guo, et al.. (2010). Elements between the IgH variable (V) and diversity (D) clusters influence antisense transcription and lineage-specific V(D)J recombination. Proceedings of the National Academy of Sciences. 107(51). 22207–22212. 27 indexed citations
14.
Li, Zhe, Hui Huang, Patricia Boland, et al.. (2009). Embryonic stem cell tumor model reveals role of vascular endothelial receptor tyrosine phosphatase in regulating Tie2 pathway in tumor angiogenesis. Proceedings of the National Academy of Sciences. 106(52). 22399–22404. 28 indexed citations
15.
Kadenhe‐Chiweshe, Angela V., Kimberly W. McCrudden, Jason S. Frischer, et al.. (2008). Sustained VEGF Blockade Results in Microenvironmental Sequestration of VEGF by Tumors and Persistent VEGF Receptor-2 Activation. Molecular Cancer Research. 6(1). 1–9. 64 indexed citations
16.
Noguera‐Troise, Irene, Christopher Daly, Nicholas Papadopoulos, et al.. (2007). Blockade of Dll4 Inhibits Tumour Growth by Promoting Non‐Productive Angiogenesis. Novartis Foundation symposium. 283. 106–125. 65 indexed citations
17.
Cao, J., R.A. Renard, Hang Song, et al.. (2006). Low Dose, Subconjunctival Administration of VEGF Trap Inhibits Suture–Induced Corneal Neovascularization and Inflammation. Investigative Ophthalmology & Visual Science. 47(13). 1626–1626. 2 indexed citations
18.
Thurston, Gavin & George D. Yancopoulos. (2001). Gridlock in the blood. Nature. 414(6860). 163–164. 20 indexed citations
19.
Bodine, Sue C., Esther Latres, Susanne Baumhueter, et al.. (2001). Identification of Ubiquitin Ligases Required for Skeletal Muscle Atrophy. Science. 294(5547). 1704–1708. 2828 indexed citations breakdown →
20.
Yancopoulos, George D., et al.. (1990). Methods for cloning and analysis of eukaryotic genes. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Peter Carmeliet Breakdown of academic impact, for papers by Kari Alitalo Breakdown of academic impact, for papers by Pierre Chambon Breakdown of academic impact, for papers by John C. Reed Breakdown of academic impact, for papers by Napoleone Ferrara Breakdown of academic impact, for papers by Nahum Sonenberg Breakdown of academic impact, for papers by Neal G. Copeland Breakdown of academic impact, for papers by Eric N. Olson Breakdown of academic impact, for papers by Steven P. Gygi Breakdown of academic impact, for papers by Josef Penninger
Rankless by CCL
2026